The FDA approval of RADIESSE for décolletage wrinkle treatment marks the first time a biostimulatory filler has been cleared for both facial and body indications in the United States. This 2026 clinical guide covers every injectable and non-injectable option available — from SKINVIVE and Sculptra to fractional lasers and RF microneedling — with guidance on patient selection and combination protocols.